Review of adverse effects of oxygen therapy in the treatment of acute myocardial infarction
Section: Artículos Científicos
Authors
Judith Sevillano Honorato
Position
Enfermera asistencial del Servicio de Urgencias del Hospital de Figueres, Girona.
Contact address
Judith Sevillano Honorato. Hospital de Figueres. Servicio de Urgencias. Ronda Rector Arolas, s/n. 17600 Figueres (Girona)
Contact email: judith.sevillano.96@gmail.com
Abstract
Introduction. Acute myocardial infarction consists of the necrosis of the myocardial cells as a consequence of prolonged ischemia caused by the sudden reduction of the coronary blood supply. Diagnosis is based on the characteristics of the pain, pain localization and radiation, symptoms that may accompany the pain and the changes in the electrocardiogram. Usual treatment includes administration of morphine, oxygen, nitroglycerin and aspirin. Currently, however, the beneficial effects of oxygen in patients with acute myocardial infarction have been questioned. Objective. To analyse the adverse effects associated with oxygen administration in patients with myocardial infarction through a literature review.
Material and methods. A literature review of scientific articles dealing with the adverse effects associated with oxygen administration was carried out.
Results. 8 scientific articles were analysed, of which 1 was a review article, 2 trials, 1 editorial and 4 systematic reviews.
Conclusions. The evidence shows that oxygen therapy in patients with AMI with saturations above 90% may worsen the evolution of the disease in the medium to long term in addition to not leading to an improvement in the patient‘s acute clinical condition.
Keywords:
Myocardial infarction; ST elevation myocardial infarction; oxygen; oxygen inhalation therapy; Systematic review
Versión en Español
Título:
Artículo completo no disponible en este idioma / Full article is not available in this language
Bibliography
1. Coll-Muñoz Y, Valladares-Carvajal F, González-Rodriguez C, Falcón-Hernandez A, Pereira-Valdés E. Infarto Agudo de Miocardio. Guía de práctica clínica. Revista Finlay [revista de Internet]. 2016;6(2):170-190.
2. Lüscher TF. ST-segment elevation myocardial infarction: the new ESC Guidelines. Eur Heart J. Enero 2018;39(2):75-8.
3. Jaffe AS. Third Universal Definition of Myocardial Infarction. Clin Biochem. Enero 2013;46(1-2):1-4.
4. Steg G, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, A. Borger M et al. Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST. Rev Española Cardiol. 2012;66(1):53.e1-53.e46.
5. Borja I, James S, Agrewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST. Revista española de Cardiología. 2017;70(12): 1082.e1-e61.
6. O‘Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Jan 29;127(4):e362-425.
7. Puymirat E, Lamhaut L, Bonnet N, Aissaoui N, Henry P, Cayla G, et al. Correlates of pre-hospital morphine use in ST-elevation myocardial infarction patients and its association with in-hospital outcomes and long-term mortality: the FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) programme. Eur Heart J. 1 de Abril 2016;37(13):1063-71.
8. Chen A, Shariati F, Chan T, Lebowitz D. A Review of Adverse Outcomes Following Intravenous Morphine Usage for Pain Relief in Acute Coronary Syndrome. Cureus. Setiembre 2018;10(9):e3246.
9. Lapostolle F, Van’t Hof AW, Hamm CW, Stibbe O, Ecollan P, Collet JP, et al. Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine. Am J Cardiovasc Drugs. Abril 2019;19(2):173-83.
10. Thiele H, Desch S, de Waha S. Acute myocardial infarction in patients with ST-segment elevation myocardial infarction: ESC guidelines 2017. Diciembre 2017;42(8):728-738.
11. Alencar Neto J. Morphine, Oxygen, Nitrates, and Mortality Reducing Pharmacological Treatment for Acute Coronary Syndrome: An Evidence-based Review. Cureus. 25 de Enero del 2018;10(1):e2114.
12. Stub D, Smith K, Bernard S, Nehme Z, Stephenson M, Bray JE, et al. Air Versus Oxygen in ST-Segment–Elevation Myocardial Infarction. Circulation. Junio 2015;131(24):2143-50.
13. Nedeljkovic ZS, Jacobs AK. Oxygen for ST-Segment–Elevation Myocardial Infarction. Circulation. Junio 2015;131(24):2101-3.
14. Hofmann R, James SK, Svensson L, Witt N, Frick M, Lindahl B, et al. DETermination of the role of OXygen in suspected Acute Myocardial Infarction trial. Am Heart J. Marzo 2014;167(3):322-8.
15. Cousins J, Wark P, McDonald V. Acute oxygen therapy: a review of prescribing and delivery practices. Int J Chron Obstruct Pulmon Dis. 24 de Mayo 2016;11(1):1067-1075.
16. Chu DK, Kim LH-Y, Young PJ, Zamiri N, Almenawer SA, Jaeschke R, et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet (London, England). Abril 2018;391(10131):1693-705.
17. Caldeira D, Vaz-Carneiro A, Costa J. Cochrane Corner: What is the clinical impact of oxygen therapy for acute myocardial infarction? Evaluation of a Cochrane systematic review. Rev Port Cardiol. Octubre 2014;33(10):641-3.
18. Cabello JB, Burls A, Emparanza JI, Bayliss SE, Quinn T. Oxygen therapy for acute myocardial infarction. Cochrane Database Syst Rev. 19 Diciembre 2016;12(12).
